| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC0407 |
| Trial ID | NCT03389035 |
| Disease | Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Completed |
| Title | Transposon-manipulated Allogeneic CARCIK-CD19 Cells in Pediatric and Adult Patients With r/r ALL Post HSCT |
| Year | 2017 |
| Country | Italy |
| Company sponsor | Fondazione Matilde Tettamanti Menotti De Marchi Onlus |
| Other ID(s) | FT01CARCIK |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||||||||
|
|||||||||||||||||